NCT06174675

Brief Summary

The aim of the study is to assess the efficacy of adding a pre-emptive combined bilateral infraorbital and infratrochlear nerve blocks with bupivacaine 0.25% in decreasing intraoperative and postoperative analgesics consumption and maintaining intraoperative hemodynamic stability during nasal surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
14 days until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

December 4, 2024

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

December 8, 2023

Last Update Submit

December 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total amount of intraoperative fentanyl

    throughout the surgery

Secondary Outcomes (6)

  • 1. Hemodynamic changes

    every 15 minutes during the surgery, upon arrival to the PACU and after 30 min.

  • The time from induction of anesthesia to the first additional dose of fentanyl intraoperative.

    throughout the surgery

  • Total amount of postoperative pethidine given

    24 hours postoperatively

  • Number of patients needed rescue analgesia intraoperative or postoperative.

    throughout the surgery and 24 hours postoperatively

  • Any complications related to the nerve block such as injection site pain, edema, hematoma or neurological deficits in the blocked area such as paresthesia or prolonged paralysis of the upper lip.

    24 hours postoperatively

  • +1 more secondary outcomes

Study Arms (2)

Study group

ACTIVE COMPARATOR

patients will receive combined bilateral infraorbital and infratrochlear nerve block. 20 patients

Procedure: combined bilateral infraorbital and infratrochlear nerve blocks

control group

NO INTERVENTION

patients will not receive the block and will receive intravenous analgesia according to standard protocol. 20 patients.

Interventions

Filling the block labelled syringe with 8 mL of bupivacaine 0.25%. Starting with Infraorbital nerve block using an extraoral approach.Inserting a 25-gauge needle laterally to the ipsilateral nostril after palpating the infraorbital ridge to locate the infraorbital foramen. Positioning of the index finger of the non-dominant hand above the infraorbital foramen and advancing the needle feeling it beneath the finger to avoid globe penetration injury. Injecting 3 mL of the study solution slowly after confirming negative aspiration of blood and taking care not to inject into the foramen itself. Shifting to infratrochlear nerve block by inserting the needle 1 cm above the inner canthus targeting the junction of the orbit and the nasal bone. Injecting 1mL of the study solution after confirming negative aspiration of blood. Performing contralateral nerve block in the same manner. Applying pressure to four injection points for one minute to prevent hematoma.

Study group

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age group: 18 - 55 years old.
  • American Society of Anesthesiologists (ASA) Physical Status Class I or II
  • Scheduled for elective nasal surgery under general anesthesia.

You may not qualify if:

  • Refusing to participate in the study or inability to provide informed consent.
  • History of allergy to the medications used in the study.
  • Contraindications to regional anesthesia (including coagulopathy, INR ≥ 1.4 and local infection).
  • Compromised renal or liver functions.
  • History of substance or alcohol abuse.
  • Pre-existing chronic pain of different etiology.
  • Psychiatric disorders.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain shams university hospitals

Cairo, Cairo Governorate, 002, Egypt

Location

Study Officials

  • Ayat Elshaer, ass.lecturer

    faculty of medicine, Ain Shams University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer of anesthesia

Study Record Dates

First Submitted

December 8, 2023

First Posted

December 18, 2023

Study Start

January 1, 2024

Primary Completion

July 1, 2024

Study Completion

September 1, 2024

Last Updated

December 4, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations